Key result
New protocol outlines the PROFID multivariable risk prediction model for SCD in post-MI patients.
Why the study?
Can a multivariable risk prediction model accurately predict the risk of sudden cardiac death in patients with prior myocardial infarction and LVEF <50%?
Can a multivariable risk prediction model accurately predict the risk of sudden cardiac death in patients with prior myocardial infarction and LVEF <50%?
This protocol outlines the development of a multivariable risk prediction model to better stratify sudden cardiac death risk in post-MI patients, aiming to improve upon current LVEF-based ICD implantation criteria.
May refine SCD risk stratification beyond LVEF in post-MI patients; leaves open clinical utility pending external validation.
Introduction Sudden cardiac death (SCD) is the leading cause of death in patients with myocardial infarction (MI) and can be prevented by the implantable cardioverter defibrillator (ICD). Currently, risk stratification for SCD and decision on ICD implantation are based solely on impaired left ventricular ejection fraction (LVEF). However, this strategy leads to over- and under-treatment of patients because LVEF alone is insufficient for accurate assessment of prognosis. Thus, there is a need for better risk stratification. This is the study protocol for developing and validating a prediction model for risk of SCD in patients with prior MI. Methods and Analysis The EU funded PROFID project will analyse 23 datasets from Europe, Israel and the US (∼225,000 observations). The datasets include patients with prior MI or ischemic cardiomyopathy with reduced LVEF<50%, with and without a primary prevention ICD. Our primary outcome is SCD in patients without an ICD, or appropriate ICD therapy in patients carrying an ICD as a SCD surrogate. For analysis, we will stack 18 of the datasets into a single database (datastack), with the remaining analysed remotely for data governance reasons (remote data). We will apply 5 analytical approaches to develop the risk prediction model in the datastack and the remote datasets, all under a competing risk framework: 1) Weibull model, 2) flexible parametric survival model, 3) random forest, 4) likelihood boosting machine, and 5) neural network. These dataset-specific models will be combined into a single model (one per analysis method) using model aggregation methods, which will be externally validated using systematic leave-one-dataset-out cross-validation. Predictive performance will be pooled using random effects meta-analysis to select the model with best performance. Ethics and dissemination Local ethical approval was obtained. The final model will be disseminated through scientific publications and a web-calculator. Statistical code will be published through open-source repositories.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2021) studied Prior myocardial infarction or ischemic cardiomyopathy (n=225,000). PROFID Risk Model was evaluated on Sudden cardiac death in patients without an ICD, or appropriate ICD therapy in patients carrying an ICD as a SCD surrogate. This study protocol outlines the development and validation of the PROFID multivariable risk prediction model for sudden cardiac death in approximately 225,000 patients with prior myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: